BR0113070A - Composições farmacêuticas contendo carbonato de lìtio - Google Patents

Composições farmacêuticas contendo carbonato de lìtio

Info

Publication number
BR0113070A
BR0113070A BR0113070-6A BR0113070A BR0113070A BR 0113070 A BR0113070 A BR 0113070A BR 0113070 A BR0113070 A BR 0113070A BR 0113070 A BR0113070 A BR 0113070A
Authority
BR
Brazil
Prior art keywords
pharmaceutical compositions
lithium carbonate
carbonate containing
containing pharmaceutical
compositions containing
Prior art date
Application number
BR0113070-6A
Other languages
English (en)
Inventor
Giulio Tarro
Original Assignee
Unihart Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT2000MI001868A external-priority patent/IT1318677B1/it
Priority claimed from ITMI20010299 external-priority patent/ITMI20010299A1/it
Application filed by Unihart Corp filed Critical Unihart Corp
Publication of BR0113070A publication Critical patent/BR0113070A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Inorganic Chemistry (AREA)
  • Psychiatry (AREA)
  • AIDS & HIV (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS CONTENDO CARBONATO DE LìTIO". A presente invenção refere-se a composição farmacêutica "Uma Vez ao Dia" contendo uma quantidade de carbonato de lítio de 300 mg a 900 mg, na forma de grânulos revestidos tendo a seguinte composição: carbonato de lítio 93%, etilcelulose 1,7%, talco 0,8%, polivinilpirrolidona 4,5%.
BR0113070-6A 2000-08-10 2001-08-06 Composições farmacêuticas contendo carbonato de lìtio BR0113070A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT2000MI001868A IT1318677B1 (it) 2000-08-10 2000-08-10 Composizione farmaceutica contenente litio carbonato.
ITMI20010299 ITMI20010299A1 (it) 2001-02-14 2001-02-14 Composizione farmaceutica contenente litio carbonato
PCT/EP2001/009054 WO2002011740A2 (en) 2000-08-10 2001-08-06 'slow release' pharmaceutical compositions comprising lithium carbonate

Publications (1)

Publication Number Publication Date
BR0113070A true BR0113070A (pt) 2003-07-08

Family

ID=26332755

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113070-6A BR0113070A (pt) 2000-08-10 2001-08-06 Composições farmacêuticas contendo carbonato de lìtio

Country Status (11)

Country Link
US (3) US6989159B2 (pt)
EP (1) EP1315480B1 (pt)
JP (1) JP2004505923A (pt)
CN (1) CN1230150C (pt)
AT (1) ATE295154T1 (pt)
AU (1) AU2001291738A1 (pt)
BR (1) BR0113070A (pt)
CA (1) CA2417930A1 (pt)
DE (1) DE60110814D1 (pt)
EA (1) EA200300128A1 (pt)
WO (1) WO2002011740A2 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20010220A1 (it) * 2001-02-05 2002-08-05 Valpharma Sa Formulazioni multiparticolate per somministrazione orale di sali di litio idonee per una somministrazione al giorno
US20040241252A1 (en) * 2003-05-29 2004-12-02 Abney Christopher Charles Pharmaceutical compositions for oral administration comprising lithium carbonate, processes of making the same, and methods of administering the same
CA2567249A1 (en) * 2004-04-19 2006-10-05 Jds Pharmaceuticals, Llc Lithium combinations, and uses related thereto
WO2008022472A1 (de) * 2006-08-23 2008-02-28 Heinz Forster Pharmazeutische zusammensetzung
WO2008067409A2 (en) * 2006-11-28 2008-06-05 Polyplus Battery Company Protected lithium electrodes for electro-transport drug delivery
WO2009006349A2 (en) * 2007-06-29 2009-01-08 Polyplus Battery Company Electrotransport devices, methods and drug electrode assemblies
US20090069740A1 (en) * 2007-09-07 2009-03-12 Polyplus Battery Company Protected donor electrodes for electro-transport drug delivery
FR2999426B1 (fr) * 2012-12-13 2015-01-02 Flamel Tech Sa Forme orale multiparticulaire a liberation immediate d'au moins un compose actif, comprenant des particules enrobees resistantes au broyage.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2016922B (en) 1978-02-17 1982-08-18 Delandale Lab Ltd Sustained release lithium carbonate tables
US4264573A (en) * 1979-05-21 1981-04-28 Rowell Laboratories, Inc. Pharmaceutical formulation for slow release via controlled surface erosion
SE509029C2 (sv) * 1988-08-16 1998-11-30 Ss Pharmaceutical Co Långtidsverkande diklofenak-natriumpreparat
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
HU206824B (en) * 1990-08-24 1993-01-28 Biogal Gyogyszergyar Process for the production of a table crystallizing in the monoclinic system, which contains light-, heat-, and moisture- sensitive active agents
JP2001518493A (ja) * 1997-10-03 2001-10-16 スミスクライン・ビーチャム・コーポレイション 炭酸リチウムの放出制御性固体投与形

Also Published As

Publication number Publication date
EP1315480A2 (en) 2003-06-04
US20050208154A1 (en) 2005-09-22
CA2417930A1 (en) 2002-02-14
US20040013746A1 (en) 2004-01-22
EP1315480B1 (en) 2005-05-11
AU2001291738A1 (en) 2002-02-18
JP2004505923A (ja) 2004-02-26
WO2002011740A3 (en) 2002-04-18
US20080124390A1 (en) 2008-05-29
ATE295154T1 (de) 2005-05-15
WO2002011740A2 (en) 2002-02-14
US6989159B2 (en) 2006-01-24
EA200300128A1 (ru) 2003-08-28
DE60110814D1 (de) 2005-06-16
CN1446082A (zh) 2003-10-01
CN1230150C (zh) 2005-12-07

Similar Documents

Publication Publication Date Title
RS50510B (sr) Formulacije koje sadrže ekteinascidin i disaharid
ATE312843T1 (de) Neues cyclosporin mit verbesserter wirkung
DE69907977D1 (de) Pyrrolobenzodiazepine
HUP0301573A3 (en) Substituted arylpyrazines, pharmaceutical compositions containing them and their use
HUP0301577A3 (en) Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors, pharmaceutical compositions containing them and their use
EA199900373A2 (ru) Фармацевтические композиции
HUP0203973A3 (en) Heterocyclic compounds having sulfonamide groups, pharmaceutical compositions containing them and their use
IL154981A0 (en) Substituted indoles, pharmaceutical compositions containing such indoles and their use as ppay-y-binding agents
AU3073599A (en) Novel powder compositions
FR2810237B1 (fr) Composition cosmetique filmogene
FR2815851B1 (fr) Composition cosmetique filmogene
BR0106649B1 (pt) composição fertilizante contendo enxofre.
HRP20030154B1 (en) Preparation of risperidone
HUP0101333A3 (en) Diazepan derivatives and their salts, pharmaceutical compositions containing the same
FR2810238B1 (fr) Composition cosmetique filmogene
FR2814673B1 (fr) Composition cosmetique filmogene
DE69925167D1 (de) Hochwitterungsbeständige pulverlackzusammensetzung
FR2810236B1 (fr) Composition cosmetique filmogene
FR2810239B1 (fr) Composition cosmetique filmogene
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
AU2003245920A1 (en) Perfume composition
BR0113070A (pt) Composições farmacêuticas contendo carbonato de lìtio
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
ATE297187T1 (de) Resorcinenthaltende zusammensetzung
HUP0204422A3 (en) Calcium dicarboxylate ethers, methods of making the compounds, and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O, 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2021 DE 29/09/2009.